Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma
Thamir Mahgoub(Dublin City University), John Crown(St. Vincent's University Hospital)
Cited by 20
Related Papers
MYC as a target for cancer treatment
|Cancer Treatment Reviews|2021|528
Effects of HER Family–targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer
|Clinical Cancer Research|2020|75